Dediabetes Logo
Questions
Published answers connected to evidence
Clinical Reference
Detailed intervention and outcome dossiers
Latest Research
Newest studies
About
How deDiabetes works
Settings
Login / Sign-up
Research Summary
Analyzed using Evidence Intelligence™

Smartphone app improves diabetes self-management in young patients

Powered by the Dediabetes Evidence Intelligence™ framework

Last updated September 9, 2026

Key finding

Mean HbA1c levels dropped from 8.3% to 7.4% in Group A.

This study evaluated the effectiveness of the 'Ana wa Soukari' smartphone application for self-management of Type 1 Diabetes, showing improvements in HbA1c levels and reduced hypoglycaemic events.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the effectiveness of the 'Ana wa Soukari' smartphone application for self-management of Type 1 Diabetes, showing improvements in HbA1c levels and reduced hypoglycaemic events.

Clinical relevance

Improving self-management tools for Type 1 Diabetes is crucial as it can lead to better health outcomes. This study highlights the potential of smartphone applications to enhance patient engagement and diabetes management, which could reduce complications associated with poorly controlled diabetes.

Keep in mind

The study's sample size may limit the generalizability of the findings. The duration of the study was only three months, which may not capture long-term effects. Potential biases in self-reported data could affect outcome accuracy.

Published in

Journal Reference

Publication details and source links for this paper.

Nada D, Salma B, Imane R, et al. Effectiveness of a Smartphone Application for Self-Management of Type 1 Diabetes. The Review of Diabetic Studies : RDS. 2023;19(2):71-76. doi:10.1900/RDS.2023.19.71

View DOIView on PMC

Main Effects

Mean HbA1c levels decreased by 0.9% in the intervention group (P=0.016).

Hypoglycaemic events reduced by 1.8 events per week in the intervention group (P<0.001).

DTSQs scores increased by 4 points in the intervention group (P<0.001).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Ana wa Soukari and HbA1c, Overall health-promoting lifestyle score measured by HPLP-II, Treatment satisfaction.

This study contributes evidence to

Intervention

Ana wa Soukari

Outcome

HbA1c

Evidence topic

HbA1c Reduction

Primary intervention

Ana wa Soukari

Primary outcomes

  • HbA1c
  • Overall health-promoting lifestyle score measured by HPLP-II
  • Treatment satisfaction

Evidence topics

HbA1c Reduction

Primary intervention

Ana wa Soukari

Primary outcomes

HbA1cOverall health-promoting lifestyle score measured by HPLP-IITreatment satisfaction

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

3
Evidence pairs
3
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 59

1

Related topics

3

Evidence pairs

544

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 3 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

HbA1c Reduction

matched_outcome

Core evidence

Study findings

The primary outcomes reported in this study.

HbA1c

Ana wa Soukari → HbA1c

Ana wa Soukari → HbA1c

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Overall health-promoting lifestyle score measured by HPLP-II

Ana wa Soukari → Overall health-promoting lifestyle score measured by HPLP-II

Ana wa Soukari → Overall health-promoting lifestyle score measured by HPLP-II

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
25
Negative
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Treatment satisfaction

Ana wa Soukari → Treatment satisfaction

Ana wa Soukari → Treatment satisfaction

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • HbA1c levels dropped significantly by 0.9% in the app group.
  • Participants experienced 1.8 fewer hypoglycaemic events per week.
  • Satisfaction scores improved by 4 points in the intervention group.
who this applies

Who this applies to

  • Individuals aged 18 and older with Type 1 Diabetes.
  • Patients seeking improved self-management tools for diabetes.
keep in mind

Keep in Mind

  • Results may not apply to younger populations or those with Type 2 Diabetes.
  • The study was limited to a three-month follow-up period.
  • Further research is needed to assess long-term effectiveness and adherence.
between the lines

Between the Lines

  • The study's sample size may limit the generalizability of the findings.
  • The duration of the study was only three months, which may not capture long-term effects.
  • Potential biases in self-reported data could affect outcome accuracy.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Powered by the Dediabetes Evidence Intelligence™ framework

This study contributes to evidence on Ana wa Soukari and HbA1c, Ana wa Soukari and Overall health-promoting lifestyle score measured by HPLP-II.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Devices & Technology
Detailed evidence

Ana wa Soukari → HbA1c

Devices & Technology

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
View evidence

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Ana wa Soukari lower HbA1c?

Emerging Evidence

Ana wa Soukari appears to lower HbA1c.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence

Does Ana wa Soukari improve treatment satisfaction?

Emerging Evidence

Ana wa Soukari appears to improve treatment satisfaction.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Treatment satisfaction

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence

Does Ana wa Soukari improve overall health-promoting lifestyle score measured by hplp-ii?

Emerging Evidence

Ana wa Soukari may worsen overall health-promoting lifestyle score measured by hplp-ii or be associated with harm.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Overall health-promoting lifestyle score measured by HPLP-II

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | moderate negative | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Evidence topics

Follow the topics this study contributes to.

HbA1c Reduction Evidence Hub

Explore in Evidence Explorer

Open broader Evidence Explorer views for this relationship.

All studies on Ana wa Soukari and HbA1cAll studies on Ana wa Soukari and Overall health-promoting lifestyle score measured by HPLP-IIAll studies on Ana wa Soukari and Treatment satisfaction

Related research

Read related research summaries.

Flexible Insulin Therapy Improves Diabetes ControlHRS-7535 improves glycemic control in adults with type 2 diabetesQCC Model Enhances Diabetes ManagementAdding medications improves blood sugar control in diabetes patients.Adding sitagliptin to insulin improves glycemic control in type 2 diabetes

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.